Drug Delivery

Drug delivery is the method in which a pharmaceutical compound is administered to promote a therapeutic effect. Drug delivery routes can include oral, transdermal, nasal, and sublingual application and can directly impact a drugs efficacy. In this drug delivery content hub, you can discover editorial coverage of the latest research and industry trends impacting drug delivery and novel drug discovery.

  • Shifting Sands: From Sensitivity to Accuracy in Bioanalysis

    In recent years, regulatory focus has notably shifted from sensitivity to accuracy, underscoring a pivotal change in how we approach toxicological assessments. While sensitivity remains a critical requirement, our advancing understanding of toxicology has highlighted the crucial need for precise target analysis. This shift in focus is particularly ... read more

  • Executive Q&A: Biopharmaceuticals/ Biosimilars

    The market need is the main driver. Today, access to quality Biologics drugs is limited to a minority of the patients around the world. Increasing the supply of biosimilars worldwide should contribute to making based treatment more available. read more
Page

  • Whitepaper: Key Considerations for Extracting Proteins from Recombinant Host Cells

    In the biopharmaceutical industry, quality is pivotal. For a final product to meet quality standards, quality must be built into the production process. Biopharmaceuticals, however, are made from biologically sourced materials, which are inherently variable. read more

  • eBook: Glass Related Recalls in Pharma

    Typically, drug recalls fall into two categories: recalls issued for the cracking or breaking of glass vials and recalls issued for the presence of particulates being detected in the drug solution. read more

  • Whitepaper: Purification Strategies for Recombinant Therapeutic Proteins

    Many biopharmaceuticals are recombinant proteins obtained by biotechnological processes. In various steps of the pharmaceutical value chain, from drug discovery, to development and manufacturing, to bioprocessing, these proteins must be extracted from their complex biological sources, typically microorganisms or genetically ... read more

  • Whitepaper: Global regulators’ FAQs on CMC in IND/BLA filing

    Mammalian cell cultures used in the manufacturing of therapeutics must be tested to ensure lack of mycoplasmal contamination. Previously, the only test for mycoplasma accepted by regulatory agencies was a culture-based test such as the test detailed in USP <63>. Currently, regulatory agencies globally accept nucleic acid testing ... read more

  • Whitepaper: How to Develop an Efficient Drug Formulation Process

    Developing an efficient drug formulation development process requires expertise. Ascendia Pharmaceuticals, a leading specialty CDMO, has been recognized as a Partner of Choice by many drug companies because they have solved complex formulations for nearly a decade. Ascendia’s white paper details how to implement a drug discovery... read more
Page

Webinars

  • <<
  • >>